'Potential New Standard' for Progressing Desmoid Tumors

(MedPage Today) -- PARIS--Progression-free survival (PFS) was significantly prolonged in patients with progressing desmoid tumors treated with an investigational gamma secretase inhibitor in a phase III trial.
In the international DeFi study...